Free Trial

NOVONIX (NASDAQ:NVX) Given Sell (E+) Rating at Weiss Ratings

NOVONIX logo with Computer and Technology background

Key Points

  • NOVONIX (NASDAQ: NVX) has been restated with a "sell (e+)" rating by Weiss Ratings, indicating caution for potential investors.
  • In contrast, Wall Street Zen has upgraded NOVONIX to a "hold" rating, suggesting a more neutral position.
  • The company's shares opened at $1.93, with a 52-week trading range of $0.81 to $2.73, highlighting significant volatility in its stock price.
  • Five stocks we like better than NOVONIX.

NOVONIX (NASDAQ:NVX - Get Free Report)'s stock had its "sell (e+)" rating restated by research analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.

Separately, Wall Street Zen raised NOVONIX to a "hold" rating in a research report on Friday, September 26th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of "Sell".

Check Out Our Latest Stock Analysis on NOVONIX

NOVONIX Stock Performance

NASDAQ NVX opened at $1.93 on Wednesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 0.93 and a quick ratio of 0.90. The business's 50 day moving average price is $1.35 and its 200-day moving average price is $1.24. NOVONIX has a fifty-two week low of $0.81 and a fifty-two week high of $2.73.

About NOVONIX

(Get Free Report)

NOVONIX Limited provides battery materials and development technology for battery manufacturers, materials companies, automotive original equipment manufacturers (OEMs), and consumer electronics manufacturers in North America, Asia, Australia, and Europe. It operates through Battery Materials and Battery Technology segments.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in NOVONIX Right Now?

Before you consider NOVONIX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NOVONIX wasn't on the list.

While NOVONIX currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.